Introduction {#s0005}
============

Ecthyma gangrenosum (EG) is a well-described skin manifestation of *Pseudomonas aeruginosa* septicemia in immunocompromised patients. EG is most commonly seen in *Pseudomonas* septicemia. However, it may be seen in association with infections caused by other gram-negative bacteria and fungi and can rarely be caused by gram-positive organisms such as *Staphylococcus* and *Streptococcus* species. We report a case of a 54-year-old African American female with neutropenia in the setting of metastatic gastric adenocarcinoma and recent chemotherapy who developed EG-like lesions due to methicillin susceptible *Staphylococcus aureus*. In addition, we also review the literature and discuss all reported cases of *S aureus*-associated EG manifestation, diagnosis, and treatment.

Case report {#s0010}
===========

A 54-year-old African American female with a medical history significant for systemic lupus erythematosus on chronic therapy with systemic steroids and hydroxychloroquine was recently diagnosed with gastric adenocarcinoma with metastatic liver lesions. She presented to our hospital with fever and painful skin lesions. The patient had received a first round of chemotherapy with 5-fluorouracil, cisplatin, and trastuzumab. Seven to ten days after the last dose of chemotherapy she noted multiple painful skin lesions.

On admission, the patient's blood pressure was 86/52 mmHg, heart rate 122 bpm, and temperature 103.7 °F. The patient was alert, oriented, and not in any acute distress. Skin examination revealed three 3-12--mm, tender, indurated, and erythematous papules and plaques with violaceous-gray centers located on the left popliteal fossa, right anterolateral knee, and right external ear canal. Additionally, there were 4-5--mm vesicles at the right mandibular angle and right arm, and pustules scattered on the mid chest (see [Figs. 1](#f0005){ref-type="fig"} and [2](#f0010){ref-type="fig"}).

Admission laboratory studies revealed pancytopenia and elevated erythrocyte sedimentation rate and C-reactive protein. Additional results are shown in [Table 1](#t0005){ref-type="table"}.

Three sets of blood cultures obtained prior to administration of antibiotic therapy showed no growth. Fungal blood cultures were negative. Chest imaging did not reveal any pathology. Transthoracic and transesophageal echocardiograms showed normal valvular function without vegetations.

The patient's initial therapy with intravenous cefepime, vancomycin, and metronidazole was changed to intravenous acyclovir, vancomycin, and double pseudomonas coverage with meropenem and amikacin after evaluation by the infectious disease and dermatology teams.

Cutaneous punch biopsies were obtained from the violaceous-gray lesion on the left popliteal fossa and a pustule from the chest. Histopathology of the violaceous-gray lesion revealed prominent edema and numerous gram-positive cocci in the superficial dermis (see [Figs. 3](#f0015){ref-type="fig"} and [4](#f0020){ref-type="fig"}). Additionally, there was a perivascular inflammatory cell infiltrate in the superficial and deep dermis composed of lymphocytes, histiocytes, and neutrophils, as well as dilated blood vessels with extravasated erythrocytes. Special stains for acid fast bacilli and fungal organisms were negative. The chest pustule histologically demonstrated an intraepidermal pustular dermatitis with gram-positive cocci. Tissue cultures from both specimens grew methicillin-susceptible *Staphylococcus aureus*, with an oxacillin minimum inhibitory concentration of 0.5 mcg/ml.

Acyclovir, meropenem, and vancomycin were discontinued. All blood cultures remained negative throughout hospitalization, and the patient was discharged home to complete 2 weeks of intravenous oxacillin.

Discussion {#s0015}
==========

Ecthyma gangrenosum (EG) is a well-described skin manifestation of *P aeruginosa* septicemia in immunocompromised patients. EG lesions usually are round, indurated, ulcerated papules progressing into plagues with a central gray-black eschar and surrounding erythema. Lesions may evolve from initial vesiculobullous lesions and rapidly become hemorrhagic.

The clinical differential diagnosis in our case included EG associated with invasive pathogens: *Pseudomonas*, *Staphylococcus* sp., fungal infection such as *Aspergillus* sp., *Fusarium* sp., disseminated varicella zoster virus, and herpes simplex virus; noninfectious entities such as vasculitis were also considered. Ecthyma ("deep impetigo") was not considered in our differential diagnosis, as clinically the skin lesions in our patient did not start as superficial epidermal erosions and crusting that progressed deeper into the dermis to create crusted ulcers.

EG is most commonly seen in *Pseudomonas* septicemia; however, it may be seen in association with infections caused by other gram-negative bacteria, such as *Aeromonas hydrophilia, Klebsiella pneumonia, Escherichia coli, Neisseria gonorrhea, Citrobacter freundii, Serratia marcescens*, and fungi including *Candida albicans*, *Aspergillus fumigatus, Fusarium solani, Pseudallescheria boydii* and *Curvularia* sp. The viral pathogens herpes simplex viruses 1 and 2 and varicella-zoster virus can be associated with EG as well. Rarely, EG can be caused by gram-positive organisms such as *Staphylococcus* and *Streptococcus* species ([@bb0015], [@bb0030]).

A review of English literature in PubMed between January 1, 1990, to January 31, 2016, was performed using the following keywords: non-pseudomonal ecthyma gangrenosum, methicillin-resistant *Staphylococcus aureus,* and methicillin-susceptible *Staphylococcus aureus*. This search revealed 5 other reported cases of EG associated with *S aureus* infection. EG usually occurs in the patients with underlying immunodeficiency. Predisposing factors include neutropenia, malignancy, burns, malnutrition, and tuberculosis. Most of the patients described in the literature had underlying immunosuppression ([@bb0040]).

EG can occur in association with bacteremia or in patients with sterile blood cultures ([@bb0010], [@bb0030]). Skin lesions in patients with bacteremia represent hematogenous dissemination of organisms from distant sites, and blood cultures are positive in these patients. In those patients with sterile blood cultures and EG, skin lesions are thought to be associated with direct pathogen inoculation into the skin. However, as previously discussed, this would not explain the simultaneous presence of multiple discrete, distant skin lesions. Blood cultures were negative in five out of six reported *Staphylococcus* cases, including our case ([Table 2](#t0010){ref-type="table"}). Our patient had multiple sterile blood cultures but had organisms cultured from three different skin lesions. This could be explained by transient bacteremia that was undetected in cultures. Interestingly, in the case presented by Song et al., organisms were not found in tissue stains, and skin lesions were therefore thought to be associated with toxins produced by *S aureus* ([@bb0040]). However, *Staphylococcus* was cultured from tissue culture.

Upon review of all published case reports, methicillin resistance was more commonly associated with EG lesions, as only two patients out of six had methicillin-susceptible *Staphylococcus* cultured from skin lesions. Lesions had a wide anatomic distribution but were more commonly seen on the trunk and upper and lower extremities and less commonly on the face. Lesions may be macular, papular, plaque-like, ulcerated, bullous, and/or vesicular. All lesions had necrotic-appearing centers with surrounding erythema and soft tissue induration (see [Table 2](#t0010){ref-type="table"}).

Histopathologic evaluation of skin biopsies revealed dermal edema with neutrophil infiltration and gram positive cocci in most of the reported *S aureus*--associated cases. Extensive dermal and epidermal necrosis was reported only in 2 cases ([Table 2](#t0010){ref-type="table"}). Histopathologic evaluation of skin biopsies from our patient did not reveal the typical findings of EG, such as blood vessel invasion, vasculitis, and necrosis. However, given the wide anatomic distribution of multiple skin lesions, typical clinical appearance and systemic symptoms that are not generally seen with deep impetigo, the lesions in our patient are most consistent with EG.

As opposed to other infections caused by *S aureus,* written treatment guidelines for staphylococcal EG do not exist. Given skin and soft tissue involvement, one could consider treating patients based on Skin and Soft Tissue Infection Guidelines ([@bb0020]), which would comprise 5 to 10 days of therapy, individualizing based on the patient's clinical response. Clindamycin, trimethoprim-sulfamethoxazole, tetracycline (doxycycline or minocycline), or linezolid could be used to treat methicillin-resistant *S aureus* infection ([@bb0020]). For methicillin-susceptible strains, dicloxacillin, cephalexin, nafcillin, or cefazolin can be employed.

In a hospitalized patient, especially in patients with febrile neutropenia and complicated skin and soft tissue infections, surgical debridement plus intravenous antibiotic therapy is recommended. According to the Skin and Soft Tissue Infection Guidelines, treatment duration in febrile neutropenic patients should be 7 to 14 days with intravenous therapy. Given the wide distribution of skin lesions and possibility of disseminated infection, we recommend that treatment be prolonged to the duration recommended to treat noncomplicated blood stream infections.

Treatment should be initiated with intravenous vancomycin, daptomycin, cefazolin, nafcillin, or oxacillin for at least 2 weeks depending on the susceptibility pattern for uncomplicated bacteremia ([@bb0020], [@bb0045]). Empiric therapy with broader spectrum antibiotics, such as vancomycin, daptomycin, or linezolid should be considered pending culture data. Duration of the pathogen-directed therapy in case reports ranged from 14 to 28 days, with intravenous as opposed to oral therapy being the delivery of choice ([@bb0040]). Our patient received 2 weeks of intravenous oxacillin.

Conclusion {#s0020}
==========

EG is most commonly seen in septicemia caused by *P aeruginosa* in an immunocompromised host. However, in the presence of neutropenia and immunosuppression, EG lesions can be caused by gram-positive bacteria such as *S aureus*. These patients may have negative blood cultures. Gram positive coverage should be considered early in patients without clinical improvement.
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![Indurated, erythematous papule with violaceous-grey center.](gr1){#f0005}

![Indurated, erythematous plaque with central edema.](gr2){#f0010}

![Prominent superficial dermal edema and a dense perivascular inflammatory infiltrate with neutrophils.](gr3){#f0015}

![Numerous gram-positive cocci in the upper dermis.](gr4){#f0020}

###### 

Blood Test Performed on Admission.

Table 1.

  Blood test                                   Patient's results   Normal reference range
  -------------------------------------------- ------------------- -----------------------------------------------
  **White blood cell count**                   0.8 × 10^3^/uL      3.6-11.0 × 10^3^/uL
  **Absolute neutrophil count**                0.4 × 10^3^/uL      1.4-6.3 × 10^3^/uL
  **Platelet count**                           78 × 10^3^/uL       150-440 × 10^3^/uL
  **Hemoglobin**                               7.7 g/dL            12.0-16.0 g/dL
  **Erythrocyte sedimentation rate**           150 mm/h            0-20 mm/h
  **C- reactive protein**                      132.9 mg/L          \< 1.0 mg/L
  **Creatinine**                               0.9 mg/dL           0.6-1.2 mg/dL
  **Blood urea nitrogen**                      10 mg/dL            8-24 mg/dL
  **Beta-D glucan**                            31 pg/mL            \< 31 pg/mL is negative, \> 80 pg/mL positive
  **Aspergillus Galactomannan index by EIA**   0.08                index equal to or greater than 0.5 positive

###### 

Case Reports of Patients with *Staphylococcus aureus* Ecthyma Gangrenosum.

Table 2.

  Author (location)                                                                   [@bb0040] (PA)                                                                                                                                                                  [@bb0035] (Turkey)                                                                                [@bb0050] (Japan)                                                                    [@bb0005] (PA)                                                                                                                [@bb0025] (FL)                                                                                                                                                 UCONN, 2015 (CT) Our reported case.
  ----------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------
  Underlying medical condition                                                        Healthy 15-month- old girl                                                                                                                                                      69-year-old male with COPD                                                                        40 year old with AIDS, MRSA skin abscess 2 weeks prior the admission                 35 year old with T-cell ALL, with recent chemotherapy (2 weeks prior)                                                         8-month-old infant with transient neutropenia                                                                                                                  54-year-old female with SLE and metastatic gastric adenocarcinoma with recent chemotherapy (7-10 days prior)
  MRSA vs MSSA                                                                        MSSA                                                                                                                                                                            MRSA                                                                                              MRSA                                                                                 MRSA                                                                                                                          MRSA                                                                                                                                                           MSSA
  Blood cultures positive (+) vs negative (--)                                        (--)                                                                                                                                                                            (+)                                                                                               (--)                                                                                 (--)                                                                                                                          (--)                                                                                                                                                           (--)
  Lesion cultures (+) vs (--):GS: HP                                                  Culture: MSSA                                                                                                                                                                   Cultures MRSA                                                                                     Culture: negative                                                                    Culture: MRSA                                                                                                                 Culture: MRSA (tissue)                                                                                                                                         Culture MSSA
  GS: no organism                                                                     GS: NR                                                                                                                                                                          GS: NR                                                                                            GS: GPC in clusters                                                                  GS: NR                                                                                                                        GS: GPC                                                                                                                                                        
  HP: no organism                                                                     HP: NR                                                                                                                                                                          HP: NR                                                                                            HP: NR                                                                               HP: NR                                                                                                                        HP: GPC                                                                                                                                                        
  (cultures from prior skin abscess + MRSA)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  Location of the lesion(s)                                                           Chest, axilla, and shoulders                                                                                                                                                    Upper and lower extremities                                                                       Trunk, lower extremities                                                             Buttocks, bilateral upper thighs, lower abdomen                                                                               Face, neck, back, genitalia                                                                                                                                    Face, upper and lower extremities, trunk
  Description of the lesion                                                           Eight purpuric, indurated plaques and nodules with ovoid necrotic centers                                                                                                       Macular lesions evolved to bullae over the 3 days with necrotic center and surrounding erythema   Multiple deep, punched-out ulcerations with necrotic base and surrounding erythema   Tender hemorrhagic bullae with surrounding erythema                                                                           Edematous papules, purplish-red with necrotic centers                                                                                                          Multiple vesicular lesions, necrotic macules, gunmetal gray color, indurated, tender with erythematous soft tissue edema surrounding the central necrosis
  Histopathology                                                                      Dyskeratotic keratinocytes and focal spongiosis of the epidermis. Dermal infiltration with neutrophils, lymphocytes and karyorrhectic debris surrounding dermal blood vessels   No biopsy performed                                                                               No biopsy performed                                                                  Numerous bacteria in the dermis without inflammatory infiltrate, and with dermal/epidermal edema, necrosis, and hemorrhages   Large vessel vasculitis in the superficial subcutis, foci of dermal necrosis with overlying epidermal necrosis with bullae, and numerous gram-positive cocci   **Necrotic eschar:** edema, dilated blood vessels and superficial infiltrates of lymphocytes, histiocytes, and neutrophils were present within dermis
  **Vesicular lesion:** intraepidermal pustular dermatitis with gram-positive cocci                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  Treatment and duration                                                              14 days of IV therapy with doxycycline, followed by PO cephalexin                                                                                                               Ampicillin/sulbactam                                                                              Linezolid 4 weeks PO                                                                 Vancomycin IV, (duration not reported)                                                                                        Vancomycin IV 14 days                                                                                                                                          Vancomycin + nafcillin total 2 week IV therapy
  \+ meropenem                                                                        Initial antibiotic therapy (vancomycin, cefepime, amikacin)                                                                                                                     Initial antibiotic therapy (vancomycin, meropenem, amikacin, acyclovir)                                                                                                                                                                                                                                                                                                                                                                                                             
  \+ teicoplanin IV                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  Outcome                                                                             Was discharged                                                                                                                                                                  Died---septic shock                                                                               Was discharged                                                                       Was discharged                                                                                                                Was discharged                                                                                                                                                 Was discharged

COPD, chronic obstructive pulmonary disease; MRSA, methicillin resistant Staphylococcus aureus; ALL, acute lymphoblastic leukemia; SLE, systemic lupus erythematosus; MSSA, methicillin sensitive Staphylococcus aureus; GS, gram stain; HP, histopathology stain; NR, not reported; GPC, gram positive cocci; IV, intravenous; PO, oral administration of medication.
